Back to Research Home
BROBrown & Brown Inc
Financials · Insurance Brokers · Large
$72.97−2.04%
As of 23 Oct 2026Mkt cap $24.1B
Stage 13
AVOID
Fundamentals
38.9/75
Technical
10.5/15
Independent
49.4/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +21.0%
- 3M
- +4.7%
- 6M
- +10.7%
- 1Y
- −18.2%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 22.9xHist median 27.5x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 15.8x
- FCF yield
- 6.3%
Quality
- ROIC
- —
- Operating margin
- —
- FCF margin
- 23.4%
- Current ratio
- 1.0x
Growth
- Revenue growth
- +22.8%Latest FY YoY
- Revenue CAGR
- +17.9%
- EPS CAGR
- +11.2%
- FCF CAGR
- +16.0%
Capital
- Share-count trend
- +5.5%3Y annualised
- Net debt
- $6.0B4.1x OCF
Annual trend
- CAGR 2021–2025
- +17.9%
- Latest · 2025
- $6B
- YoY
- +22.8%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- WATCH · RECHECK REQUIRED
Key takeaway
Acquisition-led scale remains valuable, but Q2 organic revenue fell 0.7% and adjusted margin compressed; completed research does not establish a thesis break, only weaker organic momentum and integration risk.
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-10-26
- Price moved +18.3% since the last four-lens research baseline.
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- early-recovery
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded